Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Timothy S. Blackwell(Vanderbilt University), Jerry P. Eu(National Heart Lung and Blood Institute), Dean Sheppard(University of California, San Francisco), Imre Noth(University of Chicago), Robin R. Deterding(Robin Medical (United States)), Kevin R. Flaherty(Pulmonary and Critical Care Associates), James S. Hagood(University of California San Diego), Andrew M. Tager, Ganesh Raghu(University of Washington), Jeffrey C. Horowitz(The Ohio State University Wexner Medical Center), Bethany B. Moore(Michigan Medicine), Erica L. Herzog(Yale University), Shelia M. Violette(Biogen (United States)), Harold A. Chapman(University of California, San Francisco), Thomas H. Sisson(Pulmonary and Critical Care Associates), Luis A. Ortiz(University of Pittsburgh), Zea Borok(University of Southern California), Kevin K. Brown(Boston Children's Hospital), Daniel J. Tschumperlin(Mayo Clinic in Florida), Christine Kim Garcia(NewYork–Presbyterian Hospital), Rebecca G. Wells(University of Pennsylvania), Craig A. Henke(University of Minnesota), Peter B. Bitterman(University of Minnesota), Eric S. White(University of Michigan–Ann Arbor), Talmadge E. King, Ziv Bar‐Joseph(Carnegie Mellon University), James E. Loyd, Gregory P. Cosgrove(National Jewish Health), Ramona L. Doyle(Roche (Switzerland)), Michael R. Blackburn(The University of Texas Health Science Center at Houston), Harold R. Collard(University of California, San Francisco), Tim D. Oury(University of Pittsburgh), Kevin J. Anstrom(University of North Carolina at Chapel Hill), Julie Olsson(Roche (United States)), Paul W. Noble(Cedars-Sinai Medical Center), Cory M. Hogaboam(University of Michigan–Ann Arbor), Victor J. Thannickal(Pulmonary and Allergy Associates), Thomas A. Wynn(National Institutes of Health), Patricia J. Sime(University of Rochester), Naftali Kaminski(Yale University), David A. Schwartz(University of Colorado Anschutz Medical Campus), Fernando J. Martínez(University of Michigan–Ann Arbor), William Bradford, William E. Lawson(VA Tennessee Valley Healthcare System), Clay B. Marsh(The Ohio State University), Jesse Roman(University of Louisville), Timothy E. Weaver(University of Cincinnati Medical Center), Thomas G. O’Riordan(Gilead Sciences (United States))
American Journal of Respiratory and Critical Care Medicine
October 25, 2013
Cited by 247
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k